Detection and Quantification of Glycosylated Peptides
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- REGENERON PHARMACEUTICALS, INC., Tarrytown, New York has been assigned a patent (No. US 12157756 B2, initially filed Sept. 1, 2023) developed by Avraham Z. Rosenberg, Passaic, New Jersey, and Biao Shen, Dobbs Ferry, New York, for "Detection and quantification of glycosylated peptides." . . .